We also review recent studiesshowing that the nuclear receptor FXR/SHP cascade pathway which controlsexpression of miR-34a and its target SIRT1 in normal conditions and isdysregulated in metabolic disease states. This evidence concerns the gene SIRT1 and metabolic disease.